The European Union fined Israel’s Teva Pharmaceutical 462.6 million euros, saying it abused its market position in a way that might have delayed competitors from entering the multiple sclerosis market.
Related Posts
Financial Services Roundup: Market Talk
Read about Klarna, BBVA, bitcoin and more in the latest Market Talks covering Financial Services.
DirecTV Pursues Sports Fans With New, Slimmer Streaming Bundle
- staff
- January 14, 2025
- 0
The MySports package includes access to many major sports, but some holes remain.
Dow Shares Retreat on Weak Forecast for 3Q
Dow said its third-quarter results are expected to come in lower after an unplanned event in late July at an ethylene cracker in Texas.